18026100|t|Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
18026100|a|Using transgenic mice expressing human cystatin C (encoded by CST3), we show that cystatin C binds soluble amyloid-beta peptide and inhibits cerebral amyloid deposition in amyloid-beta precursor protein (APP) transgenic mice. Cystatin C expression twice that of the endogenous mouse cystatin C was sufficient to substantially diminish amyloid-beta deposition. Thus, cystatin C has a protective role in Alzheimer's disease pathogenesis, and modulation of cystatin C concentrations may have therapeutic implications for the disease.
18026100	0	10	Cystatin C	Gene	13010
18026100	47	66	Alzheimer's disease	Disease	MESH:D000544
18026100	67	72	mouse	Species	10090
18026100	98	102	mice	Species	10090
18026100	114	119	human	Species	9606
18026100	120	130	cystatin C	Gene	1471
18026100	143	147	CST3	Gene	1471
18026100	163	173	cystatin C	Gene	1471
18026100	222	249	cerebral amyloid deposition	Disease	MESH:D058225
18026100	301	305	mice	Species	10090
18026100	307	317	Cystatin C	Gene	13010
18026100	358	363	mouse	Species	10090
18026100	364	374	cystatin C	Gene	13010
18026100	447	457	cystatin C	Gene	1471
18026100	483	502	Alzheimer's disease	Disease	MESH:D000544
18026100	535	545	cystatin C	Gene	1471
18026100	Negative_Correlation	MESH:D058225	1471
18026100	Negative_Correlation	MESH:D000544	1471

